When: Two consecutive quarters of revenue growth ≥5% YoY without one-time benefits

Then: Fully re-engage with increased exposure

HOLD - maintain position sizing at or below benchmark with $217 stop loss; wait for confirmed breakout above 50 SMA with volume or failed retest of $217 crash low before adding exposure

• Together AI deal is only $240M against $67.5B revenue base (0.39%), too small to constitute a strategy inflection
• Cluster deployment is Q1 2027 — five-plus months out — and the 7-day +4.42% bounce suggests much of the narrative is already priced in
• Technical structure remains bearish: 50 SMA still declining (not basing), MACD negative at minus 5.61, price 8.6% below 50 SMA and 11.5% below 200 SMA
• The 7/14 crash cause is unidentified — 25%+ single-day move on 67.4M shares vs. typical 3-6M volume creates unexploded catalyst risk
• Valuation framework: PEG of 2.4 on 1-2% historical growth is genuinely elevated; Forward P/E of 18.1x is fair value at best, slight premium given lower growth profile
• Macro headwind: Higher-for-longer rates compress tech multiples and make 2.86% dividend yield uncompetitive against 4%+ 10-year Treasuries
• Expected value probabilities (40% downside to $200, 35% sideways, 25% breakout to $290) are constructed numbers, not market-implied; crash low of $217 was already tested, making the 40% downside scenario asymmetric
• Forward-looking catalysts (Together AI, Q3 earnings, quantum thesis) are not differentiating — all beaten-down names have forward-looking catalysts
• CEO has publicly warned about AI capex sustainability, suggesting internal caution about durability of AI infrastructure trade
• Discipline protected capital through the 7/14 crash; anyone who initiated before that event without a stop got cut in half; stock at $236 instead of $180 validates the cautious posture

→ vs aggressive: Together AI deal at $240M (0.39% of revenue) is not a rounding error but close to one; IBM has history of AI partnership announcements producing headlines but little actual revenue; cluster goes live Q1 2027 so buying now is momentum chasing, not catching the inflection

→ vs aggressive: The declining 50 SMA is the signature of a downtrend bleeding out, not a basing pattern; MACD line remains negative at minus 5.61; the fact that 50 SMA is still falling confirms bearish trend, not a recovery; price 8.6% below 50 SMA and 11.5% below 200 SMA represents a stock in retreat, not a base

→ vs aggressive: FY2025 7.6% revenue growth is one year of acceleration against a historical track record of 1-2% growth; single-year data points do not change valuation regimes; re-rating based on best recent quarter creates momentum traps; using beta of 0.71 and dividend as reasons to pay higher is rationale for holding, not buying

→ vs aggressive: 86% probability of zero Fed cuts means no liquidity easing to support multiple expansion; higher-for-longer rates compress multiples and raise discount rates on future cash flows; 2.86% dividend yield is uncompetitive against 4%+ Treasuries for income buyers

→ vs aggressive: Expected value math assigns 25% probability to breakout with zero technical confirmation while 40% downside scenario is anchored to $217 crash low that was already tested — asymmetric in the wrong direction; fat tails do not respect neat probability bins

→ vs aggressive: Forward-looking catalysts are not guarantees: Together AI cluster could slip, Q3 earnings could disappoint on bookings, quantum thesis is years from monetization; CEO's public warnings about AI capex sustainability provide internal caution that contradicts the bullish thesis

→ vs aggressive: Attributing the 7/14 crash to 'tail risk of overreaction' without confirmed cause is the kind of confident attribution that causes losses; unidentified catalyst is unexploded ordnance in the chart; buying in front of unknown catalyst is hope, not risk management

HOLD with staged accumulation (half-size starter at $236, add on pullback to $221.51, full position on confirmed 50 SMA reclaim with volume)

• Together AI deal is a real narrative inflection but revenue doesn't go live until Q1 2027, with meaningful income statement impact 1-2 quarters later
• +4.42% 7-day bounce may be the bulk of the narrative move already; IBM is not CoreWeave and trades as a $224B incumbent
• Technical structure shows early encouraging signs: RSI recovering from 29 to 49, 10 EMA cross above is real signal, but lacks full confirmation
• MACD line still negative at minus 5.61, histogram just flipped positive; 50 SMA at $258.49 declining, 200 SMA at $266.99 declining
• A confirmed basing pattern requires MACD line to cross above signal line, 50 SMA to flatten and turn up, and price to reclaim 50 SMA with volume — zero of three conditions met
• Forward growth assumption of 4-6% is reasonable (between aggressive's 7.6% and conservative's 1-2% historical)
• Forward PEG of approximately 1.7-1.9x (elevated but not extreme)
• Forward P/E of 18.1x is fair value at low end, discount at high end depending on growth assumption used
• Staged accumulation: half-sized starter at $236, add on weakness (pullback to $221.51 Bollinger middle) if RSI stays above 40 and 10 EMA holds
• Add second tranche on confirmed 50 SMA reclaim with volume, not on initial breakout above $242.26
• Stop loss at $217 — if price breaks $217 on rising volume, exit
• Macro setup is neutral-to-slightly-supportive: IBM not high-multiple growth name, beta 0.71, dividend covered 2x by FCF
• Unknown 7/14 catalyst is a past risk substantially absorbed by the 17.8% drawdown; markets price unknown catalysts through price action
• Together AI deal is 'acknowledged but not yet validated' — next leg requires Q3 earnings commentary on AI bookings momentum or follow-on customer announcement
• HOLD preserves optionality in both directions; it is the active thesis, not the absence of one

→ vs aggressive: Overreaches by asking to capitalize the story at $236 when the cluster doesn't go live until Q1 2027; the institutional buyers they reference took 18-24 months to bake multiples at CoreWeave and Lambda, and IBM is a $224B incumbent

→ vs aggressive: Incorrectly states declining 50 SMA is 'exactly what a successful base pattern looks like in its early stage' — declining 50 SMA is bearish by construction; conflating base price action with structural confirmation which requires MACD cross, flattened 50 SMA turning up, and price reclaiming 50 SMA with volume

→ vs aggressive: Wants to add on a breakout above $242.26 — this is chasing, not disciplined accumulation; the right approach is to add on weakness to build position without requiring correct breakout timing

→ vs conservative: Uses HOLD as a shield against position sizing and risk management work, conflating sitting on hands with discipline; true discipline is active management of an existing position, not inaction

→ vs conservative: Frames the unknown 7/14 catalyst as 'unexploded ordnance' (permanently disqualifying) when price action since the crash (stabilization at $217, grinding higher for three weeks) shows the market has digested whatever happened; new information could change this, which is why the stop exists

→ vs conservative: Overstates macro headwinds; IBM is insulated from higher-for-longer rates given its defensive compounder profile (beta 0.71, forward P/E 18, dividend covered 2x by FCF) unlike high-multiple growth names with marginal cash flows

→ vs conservative: Presents 'wait for full confirmation' versus 'initiate now' as a binary when the middle path of staged accumulation on pullbacks is the optimal approach